Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol
- Resource Type
- Article
- Source
- In
International Journal of Pharmaceutics 25 June 2023 641 - Subject
- Language
- ISSN
- 0378-5173